广东微量元素科学
廣東微量元素科學
엄동미량원소과학
Guangdong Trace Elements Science
2015年
9期
47-50
,共4页
溃疡性结肠炎%美沙拉嗪%益生菌
潰瘍性結腸炎%美沙拉嗪%益生菌
궤양성결장염%미사랍진%익생균
ulcerative colitis%mesalazine%probiotics
目的:探讨美沙拉嗪联合益生菌治疗溃疡性结肠炎的临床疗效。方法选取广东省英德市中医院收治的64例溃疡性结肠炎患者作为研究对象,按照随机数字法分成两组,对照组32例患者给予单独的美沙拉嗪进行治疗;研究组32例患者给予美沙拉嗪联合益生菌治疗,比较分析两组的临床疗效与复发情况。结果研究组患者的总有效率为93.75%,对照组患者的总有效率为71.88%,研究组的临床疗效明显好于对照组(P<0.05):两组患者在治疗后的血清C-蛋白水平均有所下降,而研究组患者的下降程度明显高于对照组( P<0.01);研究组中患者复发率为12.50%,对照组患者复发率为34.38%,两组的差异具有统计学意义( P<0.05)。结论相比单纯使用美沙拉嗪,采用美沙拉嗪联合益生菌治疗溃疡性结肠炎的临床疗效更为显著,治疗后复发率低,具有临床推广使用价值。
目的:探討美沙拉嗪聯閤益生菌治療潰瘍性結腸炎的臨床療效。方法選取廣東省英德市中醫院收治的64例潰瘍性結腸炎患者作為研究對象,按照隨機數字法分成兩組,對照組32例患者給予單獨的美沙拉嗪進行治療;研究組32例患者給予美沙拉嗪聯閤益生菌治療,比較分析兩組的臨床療效與複髮情況。結果研究組患者的總有效率為93.75%,對照組患者的總有效率為71.88%,研究組的臨床療效明顯好于對照組(P<0.05):兩組患者在治療後的血清C-蛋白水平均有所下降,而研究組患者的下降程度明顯高于對照組( P<0.01);研究組中患者複髮率為12.50%,對照組患者複髮率為34.38%,兩組的差異具有統計學意義( P<0.05)。結論相比單純使用美沙拉嗪,採用美沙拉嗪聯閤益生菌治療潰瘍性結腸炎的臨床療效更為顯著,治療後複髮率低,具有臨床推廣使用價值。
목적:탐토미사랍진연합익생균치료궤양성결장염적림상료효。방법선취광동성영덕시중의원수치적64례궤양성결장염환자작위연구대상,안조수궤수자법분성량조,대조조32례환자급여단독적미사랍진진행치료;연구조32례환자급여미사랍진연합익생균치료,비교분석량조적림상료효여복발정황。결과연구조환자적총유효솔위93.75%,대조조환자적총유효솔위71.88%,연구조적림상료효명현호우대조조(P<0.05):량조환자재치료후적혈청C-단백수평균유소하강,이연구조환자적하강정도명현고우대조조( P<0.01);연구조중환자복발솔위12.50%,대조조환자복발솔위34.38%,량조적차이구유통계학의의( P<0.05)。결론상비단순사용미사랍진,채용미사랍진연합익생균치료궤양성결장염적림상료효경위현저,치료후복발솔저,구유림상추엄사용개치。
Objective To investigate clinical efficacy of mesalazine combined with probiotics in treatment of ulcerative colitis.Methods 64 patients with ulcerative colitis in our hospital were selected as study group and divided into the control group (32), treated by mesalazine and the study group(32), treated by mesalazine combined with probiotics.The clinical efficacy and relapse of two groups were observed.Results The total effective rate of the study group (93.75%) was significantly higher than that of the control group (71.88%) ( P<0.05 ).Serum C-protein levels of the study group was significantly lower than that of the control group ( P <0.01 ).The recurrence rate of the study group ( 12.50%) was significantly lower than that of the control group ( 34.38%) ( P <0.05 ).Conclusion Compared simply using the mesalazine, mesalazine combined with probiotics in treatment of ulcerative colitis has curative effect, low recurrence rate after treatment.